Loading: 100%
BIOLIFE SOLUTIONS INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 36 (as per Q3 2016)no data available
Sector Medical Instruments & Equipmen, HealthcareMedical Instruments & Equipmen, Healthcareno data available
Ticker BLFSno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,01,53,04,56,0
datesClosing price (adj.)
13.10.20175.54
11.10.20175.57
04.10.20175.62
27.09.20175.50
20.09.20175.02
13.09.20174.73
06.09.20174.73
30.08.20174.99
23.08.20174.87
16.08.20174.17
09.08.20173.66
02.08.20173.71
26.07.20173.40
19.07.20173.34
12.07.20173.11
05.07.20172.90
27.06.20172.40
20.06.20172.39
13.06.20172.27
06.06.20172.21
30.05.20172.20
23.05.20172.23
16.05.20172.15
09.05.20172.16
02.05.20172.02
25.04.20172.04
18.04.20172.02
11.04.20172.03
04.04.20172.04
28.03.20172.04
21.03.20172.05
14.03.20172.00
07.03.20172.18
28.02.20171.94
21.02.20171.98
14.02.20171.96
07.02.20171.78
31.01.20171.85
24.01.20171.89
17.01.20171.75
10.01.20171.86
03.01.20171.62
27.12.20161.63
19.12.20161.52
12.12.20161.61
05.12.20161.65
28.11.20161.60
21.11.20161.54
14.11.20161.54
07.11.20161.49
31.10.20161.60
24.10.20161.68
17.10.20161.66
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
5.54n/a
Market Capitalisation
in million USD
71n/a
Enterprise Value
in million USD
71n/a
Common Shares Outstanding
as per Sep 30, 2016
12,768,513n/a
Preferred Shares Outstanding
as per Sep 30, 2016
n/a
Average Basic Shares Outstanding
TTM
12,508,331n/a
Average Diluted Shares Outstanding
TTM
4,977,133n/a
Index Membership
n/a
Business Summary
BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation.
no data available
Key Financials & Ratios (all figures TTM as per Mar 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 7n/a
Gross Profit 4n/a
Operating Income -5n/a
EBITDA 0n/a
Net Profit -4n/a
Balance Sheet
Cash and Cash Equivalents 1n/a
Receivables 1n/a
Total Current Assets 5n/a
PP&E 1n/a
Total Assets 11n/a
Accounts Payable 1n/a
Current Debt 0n/a
Total Current Liabilities 3n/a
Long-Term Debt 1n/a
Total Liabilities 4n/a
Total Equity 7n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow -5n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 2n/a
Dividends Paid 0n/a
Financing Cash Flow 2n/a
Total Change in Cash -1n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 59.0%n/a
Operating Margin -78.7%n/a
Net Profit Margin -78.4%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 0.49n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 10.52n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.09n/a
Other Ratios
Current Ratio 143.3%n/a
Liabilities to Equity Ratio 63.4%n/a
Debt to Assets Ratio 6.6%n/a
Profit & Loss StatementP&L data quality: 48% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
2
3
6
9
6
6
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
-1
-1
-3
-5
-3
-3
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
1
1
2
4
3
4
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-2
-3
-3
-4
-6
-9
Selling, General & Administrative
-2
-2
-3
-4
-5
-7
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
0
-1
0
0
-1
-1
Depreciation & Amortization
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
-1
-1
-1
0
-3
-5
Non-Operating Income (Loss)
-1
-1
-1
-1
0
0
Interest Expense, net
-1
-1
-1
-1
0
0
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-2
-2
-2
-1
-3
-5
Abnormal Gains (Losses)
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
-2
-2
-2
-1
-3
-5
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-2
-2
-2
-1
-3
-5
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-2
-2
-2
-1
-3
-5
Minority Interest
0
0
0
0
0
1
Net Income
-2
-2
-2
-1
-3
-4
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
-2
-2
-2
-1
-3
-4
Remarks
restated on Mar 29, 2012 n/a
calculated values,
restated on Mar 29, 2013 n/a
calculated values,
restated on Feb 12, 2014 n/a
calculated values,
restated on Mar 12, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
0
0
0
0
10
4
Cash & Cash Equivalents
0
0
0
0
3
2
Short Term Investments
0
0
0
0
7
2
Accounts & Notes Receivable
0
1
1
1
1
1
Accounts Receivable, Net
0
1
1
1
1
1
Notes Receivable, Net
0
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
0
Inventories
0
1
1
0
1
2
Raw Materials
0
0
0
0
0
0
Work In Process
0
0
0
0
0
0
Finished Goods
0
0
0
0
0
0
Other Inventory
0
0
0
0
0
0
Other Short Term Assets
0
0
0
0
0
0
Prepaid Expenses
0
0
0
0
0
0
Derivative & Hedging Assets
0
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Income Taxes Receivable
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Miscellaneous Short Term Assets
0
0
0
0
0
0
Total Current Assets
1
1
2
2
12
7
Property, Plant & Equipment, Net
0
0
1
1
2
1
Property, Plant & Equipment
1
1
2
2
3
3
Accumulated Depreciation
0
0
-1
-1
-1
-1
Long Term Investments & Receivables
0
0
0
0
0
0
Long Term Investments
0
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
0
Other Long Term Assets
0
0
0
0
2
4
Intangible Assets
0
0
0
0
2
2
Goodwill
0
0
0
0
0
0
Other Intangible Assets
0
0
0
0
0
0
Prepaid Expense
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Derivative & Hedging Assets
0
0
0
0
0
0
Prepaid Pension Costs
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Investments in Affiliates
0
0
0
0
0
0
Miscellaneous Long Term Assets
0
0
0
0
0
2
Total Noncurrent Assets
0
1
2
1
4
5
Total Assets
1
2
3
3
16
12
Liabilities and owners' equity
Payables & Accruals
0 320702
3 2585209
1 1234088
2 1516890
1 1131560
2 1595577
Accounts Payable
0 117068
0 403103
1 862492
1 867070
0 474662
1 1029373
Accrued Taxes
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
0 0
2 2025961
0 0
0 0
0 0
0 0
Other Payables & Accruals
0 203634
0 156145
0 371596
1 649820
1 656898
1 566204
Short Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
0 20000
0 20000
0 131250
0 111250
0 130216
0 130216
Deferred Revenue
0 20000
0 20000
0 131250
0 111250
0 130216
0 130216
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
0 340702
3 2605209
1 1365338
2 1628140
1 1261776
2 1725793
Long Term Debt
0 0
0 0
1 838829
1 891986
1 874825
1 784458
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
11 10517269
10 10237294
13 13451685
14 14104737
0 0
0 0
Accrued Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
0 129167
0 109167
0 89167
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
10 10388102
10 10128127
13 13362518
14 14104737
0 0
0 0
Total Noncurrent Liabilities
11 10517269
10 10237294
14 14290514
15 14996723
1 874825
1 784458
Total Liabilities
11 10857971
13 12842503
16 15655852
17 16624863
2 2136601
3 2510251
Preferred Equity
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
43 42645940
43 42971005
43 43325054
44 43623716
72 71923412
73 72835845
Common Stock
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
-52 -52194852
-54 -54151491
-56 -55811077
-57 -56895237
-60 -60112987
-64 -64326923
Other Equity
0 0
0 0
0 0
0 0
0 -6448
0 -451
Equity Before Minority Interest
-10 -9548912
-11 -11180486
-12 -12486023
-13 -13271521
12 11803977
9 8508471
Minority Interest
0 0
0 0
0 0
0 0
2 2132340
1 1350900
Total Equity
-10 -9548912
-11 -11180486
-12 -12486023
-13 -13271521
14 13936317
10 9859371
Total Liabilities & Equity
1 1309059
2 1662017
3 3169829
3 3353342
16 16072918
12 12369622
Remarks restated on Mar 29, 2012 n/a restated on Mar 29, 2013 n/a restated on Feb 12, 2014 n/a restated on Mar 12, 2015 n/a restated on Feb 25, 2016 n/a restated on Nov 10, 2016 n/a
Cash Flow StatementCF data quality: 92% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-2
-2
-2
-1
-3
-5
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
Non-Cash Items
0
0
1
0
1
1
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
0
0
0
0
-1
-1
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
-2
-2
0
-1
-3
-5
Change in Fixed Assets & Intangibles
0
0
-1
0
-1
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
-8
6
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
1
1
1
1
0
-1
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
1
1
0
1
-8
4
Dividends Paid
0
0
0
0
0
0
Cash From (Repayment of) Debt
1
1
0
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
0
14
0
Increase in Capital Stock
0
0
0
0
14
0
Decrease in Capital Stock
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
1
1
0
0
14
0
Net Cash Before Disc. Operations and FX
0
0
0
0
2
0
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
0
0
0
0
2
0
Effect of Foreign Exchange Rates
0
0
0
0
0
0
Net Changes in Cash
0
0
0
0
2
0
Remarks
restated on Mar 29, 2012 n/a
calculated values,
restated on Mar 29, 2013 n/a
calculated values,
restated on Feb 12, 2014 n/a
calculated values,
restated on Mar 12, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo